Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Protagonist Therapeutics Inc buy BTIG Research

Protagonist Therapeutics Inc
Start price
€50.50
24.07.24 / 50%
Target price
€46.93
24.07.25
Performance (%)
-4.16%
End price
€48.40
25.07.25
Summary
This prediction ended on 25.07.25 with a price of €48.40. With a performance of -4.16%, the BUY prediction by BTIG_Research finished with a loss. BTIG_Research has a follow-up prediction for Protagonist Therapeutics Inc where he still thinks Protagonist Therapeutics Inc is a Buy. BTIG_Research has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Protagonist Therapeutics Inc -1.156% -1.156% 131.081%
iShares Core DAX® 0.423% 5.706% 4.696%
iShares Nasdaq 100 4.096% 16.639% 38.946%
iShares Nikkei 225® 4.469% 18.343% 50.386%
iShares S&P 500 1.788% 9.644% 26.896%

Comments by BTIG_Research for this prediction

In the thread Protagonist Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) -4.16%
Target price 46.925
Change
Ends at 24.07.25

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at BTIG Research from $41.00 to $51.00. They now have a "buy" rating on the stock.
Ratings data for PTGX provided by MarketBeat

BTIG Research 
0
Report Share
24.07.24
In the thread Trading Protagonist Therapeutics Inc
Prediction Buy
Perf. (%) -4.16%
Target price 46.925
Change
Ends at 24.07.25

Die von BTIG_Research gewählte maximale Laufzeit wurde überschritten

BTIG Research 
0
Report Share
25.07.25

Current prediction by BTIG_Research for Protagonist Therapeutics Inc

buy
Protagonist Therapeutics Inc

Start price
Target price
Perf. (%)
€66.00
28.10.25
€70.34
28.10.26
29.55%
04.05.26

BTIG Research 
28.10.25 50%